RT Journal Article
T1 Time trend in transcatheter aortic valve implantation: an analysis of the Spanish TAVI registry
A1 Jimenez-Quevedo, Pilar
A1 Munoz-Garcia, Antonio
A1 Trillo-Nouche, Ramiro
A1 del Valle, Raquel
A1 de la Torre Hernandez, Jose Maria
A1 Salido, Luisa
A1 Gutierrez, Enrique
A1 Pan, Manuel
A1 Sanchez-Gila, Joaquin
A1 Garcia del Blanco, Bruno
A1 Moreno, Raul
A1 Blanco Mata, Roberto
A1 Francisco Oteo, Juan
A1 Amat-Santos, Ignacio
A1 Regueiro, Ander
A1 Ten, Francisco
A1 Manuel Nogales, Juan
A1 Fernandez-Nofrerias, Eduard
A1 Andraka, Leire
A1 Cruz Ferrer, Maria
A1 Pinar, Eduardo
A1 Romaguera, Rafael
A1 Cuellas Ramon, Carlos
A1 Alfonso, Fernando
A1 Garcia-Blas, Sergio
A1 Pinero, Antonio
A1 Ignasi, Julia
A1 Diaz Mendez, Rocio
A1 Bordes, Pascual
A1 Meseguer, Juan
A1 Nombela-Franco, Luis
A1 Spanish TAVI Registry, 
K1 Transcatheter Treatment of the Aortic Valve
K1 Records
K1 Severe Aortic Stenosis
AB Introduction and objectives: This study primary endpoint was to present the in-hospital all-cause mortality of the Spanish TAVI registry from its inception until 2018. Secondary endpoints included other in-hospital clinical events, 30-day all-cause mortality, and an assessment of the time trend of this registry. Methods: All consecutive patients included in the Spanish TAVI registry were analyzed. In this time-based analysis, the population was been divided into patients treated before 2014 (cohort A: 2009-2013) and patients treated between 2014 and 2018 (cohort B). Results: From August 2007 to June 2018, 7180 patients were included. The mean age was 81.2 +/- 6.5 years and 53% were women. The logistic EuroSCORE was 12% (8-20). Transfemoral access was used in 89%. In-hospital and 30-day all-cause mortality was 4.7% and 5.7%, respectively. On the time-based analyses during the hospital stay, the rate of myocardial infarction, stroke, need for pacemakers, tamponade, coronary obstruction, and vascular complications was similar between both groups. However, cohort B showed less need for conversion to surgery and malapposition of the valve. Also, the implant success rate increased from 93% to 96% (P
PB Permanyer publ
SN 2604-7306
YR 2020
FD 2020-04-01
LK https://hdl.handle.net/10668/28327
UL https://hdl.handle.net/10668/28327
LA en
DS RISalud
RD Apr 17, 2025